On Thursday, Century Aluminum Co (NASDAQ:CENX)’s shares dwindled -4.41%, and closed at $13.66, as Century Aluminum Co (CENX), will report first quarter 2015 earnings on Thursday, April 30th after the close of market trading. The news release will be issued through Market wired.
The corporation will hold a follow-up conference call on Thursday, April 30th at 5:00 p.m. Eastern time.
Century Aluminum Corporation, together with its auxiliaries, produces primary aluminum in the United States and Iceland. It produces standard grade and value-added primary aluminum products; and carbon products, such as anodes and cathodes. The corporation was founded in 1981 and is headquartered in Chicago, Illinois.
Halcon Resources Corp (NYSE:HK)’s shares dropped -4.40%, and settled at $1.74, during the last trading session on Thursday, after Halcon Resources Corp (HK), declared plans to release its first quarter 2015 financial results on Tuesday, May 5, 2015 after trading closes on the New York Stock Exchange.
The Corporation has also planned a conference call to talk about the release for Wednesday, May 6, 2015 at 10:00 a.m. EDT(9:00 a.m. CDT).
Halcón Resources Corporation, an independent energy corporation, is engaged in the attainment, production, exploration, and development of onshore oil and natural gas properties in the United States. The corporation primarily holds interests the Bakken/Three Forks Formations comprising about 129,000 net acres of area in North Dakota; and East Texas Eagle Ford Formations covering about 101,000 acres of area in Brazos, Burleson, and Robertson counties.
At the end of Thursday’s trade, Memorial Production Partners LP (NASDAQ:MEMP)’s shares dipped -4.32%, and closed at $16.61, as Memorial Production Partners LP (MEMP), declared the pricing of an underwritten public offering of 4,661,663 ordinary units representing limited partner interests owned by MRD Holdco LLC (MRDH) at a price to the public at $16.60 per unit. MRDH will receive all of the net proceeds from the offering. MRDH has granted the underwriters a 30-day option to purchase up to an additional 699,249 ordinary units.
Memorial Production Partners LP, through its partner, engages in the attainment, development, exploitation, and production of oil and natural gas properties. Its properties comprise of operated and non-operated working interests in producing and undeveloped leasehold acreage, and working interests in identified producing wells located in Texas, Louisiana, Colorado, Wyoming, New Mexico, and offshore Southern California.
Rite Aid Corporation (NYSE:RAD), ended its Thursday’s trading session with -4.28% loss, and closed at $8.49, after Rite Aid Corporation (RAD), stated operating results for its fourth quarter and fiscal year ended February 28, 2015.
For the fourth quarter, the corporation stated proceeds of $6.8 billion and net revenue of $1.835 billion, or $1.79 per diluted share. For the full year, the corporation stated proceeds of $26.5 billion and net revenue of $2.109 billion, or $2.08 per diluted share. Current year results for both the fourth quarter and the full year were favorably influenced by a reduction of the deferred tax asset valuation allowance and a full year provision of revenue tax expense at a statutory tax rate, the net effect of which resulted in an revenue tax benefit of $1.716 billion, or $1.67 per diluted share and $1.682 billion, or $1.65 per diluted share in the fourth quarter and full year, respectively. The corporation stated Adjusted EBITDA of $343.3 million or 5.0 percent of proceeds in the fourth quarter and $1,322.8 million or 5.0 percent of proceeds for the full year.
“In the fourth quarter, our strong growth in same-store sales and prescription count in addition to strong cost control assisted drive continued profitability,” said Rite Aid Chairman and CEO John Standley.
Full Year Results
For the fiscal year ended February 28, 2015, Rite Aid had proceeds of $26.5 billion contrast to $25.5 billion for the preceding year. Proceeds raised 3.9 percent primarily as a result of an raise in same store sales.
Same store sales for the year raised 4.3 percent comprising of a 5.8 percent raise in pharmacy sales and a 1.2 percent raise in front end sales. Pharmacy sales comprised of a negative influence of about 175 basis points from new generic introductions. The number of prescriptions filled in same stores raised 3.5 percent over the preceding year period. Prescription sales accounted for 68.8 percent of total drugstore sales, and third party prescription proceed was 97.5 percent of pharmacy sales.
Net revenue for fiscal 2015 was $2.109 billion or $2.08 per diluted share contrast to last year’s net revenue of $249.4 million or $0.23 per diluted share. Current year results were favorably influenced by the reduction of a deferred tax asset valuation allowance of $1.841 billion, partially offset by revenue tax expense of $159.0 million contrast to $0.8 million in the preceding year.
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The corporation sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
